<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01259739</url>
  </required_header>
  <id_info>
    <org_study_id>Flavanols - Exercise</org_study_id>
    <nct_id>NCT01259739</nct_id>
  </id_info>
  <brief_title>Cocoa Flavanols and Exercise Capacity</brief_title>
  <official_title>The Impact of Dietary Cocoa Flavanols on Cardio-pulmonary Exercise Capacity in Human.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize the potential improvement of cocoa flavanols on
      exercise capacity in highly trained cyclist. A placebo-controlled double-blinded randomized
      control study will be performed in 13 highly trained cyclist (crossover design). Participants
      will perform a baseline exercise testing on an ergometer. They will receive either a
      flavanol-poor or flavanol rich cocoa drink twice daily for one week before a second and third
      exercise testing is performed. The order of drinks is randomized and balanced
      (high-flavanol--&gt;low-flavanol drink or low-flavanol drink--&gt;high-flavanol drink)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      13 participants (highly-trained cyclist, accustomed to exercise testing on ergometers will be
      enrolled (VO2max&gt;50 ml/kg, FMD &gt;5%, non-smokers, no medication, no diseases, age 20-36,
      male).

      Baseline Testing:

      Participants will perform a baseline testing consisting of an ergometric test with a
      step-wise increase of workload until exhaustion to determine lactate anaerobic threshold and
      cardio-pulmonary exercise capacity. Vascular function is monitored by Doppler Ultrasound.

      In a second test, participants will perform a time trial (goal: as fast as possible)

      Flavanol intervention Participants will twice daily receive either a flavanol-poor cocoa
      drink (13mg/dl)or a flavanol-rich cocoa drink (596mg/dl) over a period of 7 days. Order is
      randomized and balanced. Subjects will crossover to the second arm after a washout period of
      7 days.

      Testing performed on baseline day is repeated after the intake of both drinks

      In a subgroup of n=6 participants, we will test whether the blood pressure cuff maneuver used
      for FMD will itself modify nitrite levels. For this the manuever will be completed 4 times
      and compared to n=6 untreated controls. in another subgroup 6 participants will receive
      4times the maneuver but reperfusion will be limited by means of an ultrasound probe.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiopulmonary exercise capacity (time to complete time trail, lactate anaerobic threshold, cardio-pulmonary exercise capacity</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Exercise Capacity</condition>
  <arm_group>
    <arm_group_label>Flavanol rich cocoa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(596 mg), dissolved in water, twice daily intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>flavanol poor cocoa drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>( 13mg) dissolved in water, twice daily intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cocoa</intervention_name>
    <description>dissolved in water twice-daily intervention</description>
    <arm_group_label>Flavanol rich cocoa</arm_group_label>
    <arm_group_label>flavanol poor cocoa drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  highly trained cyclists (VO2 peak &gt; 50 ml/kg bodyweight)

          -  refrain from cocoa ingestion during trial

          -  training continued throughout testing

          -  &gt; 20 years

          -  male

        Exclusion Criteria:

          -  &gt; 36 years

          -  poor endothelial function

          -  acute infection

          -  any chronic heart or pulmonary disease

          -  arrhythmias

          -  acute or chronic renal failure

          -  smokers

          -  cardio-vascular risk factors : diabetes mellitus, hypertension, hyperlipidemia

          -  intake of nutrition supplements (l-arginine, creatinine)

          -  intake of WADA listed doping substances
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tienush Rassaf, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heinrich Heine University Düsseldorf, NRW, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Malte Kelm, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Heinrich Heine University Düsseldorf, NRW, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heinrich-Heine-University</name>
      <address>
        <city>Duesseldorf</city>
        <state>NRW</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uniklinik-duesseldorf.de/kardiologie</url>
  </link>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2010</study_first_submitted>
  <study_first_submitted_qc>December 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2010</study_first_posted>
  <last_update_submitted>November 7, 2013</last_update_submitted>
  <last_update_submitted_qc>November 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Tienush Rassaf, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>trained cyclists</keyword>
  <keyword>no medications</keyword>
  <keyword>no diseases</keyword>
  <keyword>non-smokers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

